Business Context and Reporting Period
Company: CareTrust REIT, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 10, 2020
Reporting Period: Event date of March 10, 2020
The filing reports the execution of a new equity distribution agreement to facilitate an "at-the-market" (ATM) offering program. This filing replaces a prior ATM program dated March 4, 2019, under which no shares had been sold prior to its termination.
Key Financial Metrics
This filing does not contain audited financial statements, revenue, profit, cash flow, or margin data. The primary financial metric disclosed is the authorization for potential capital raising:
- Maximum Offering Size: Up to $500,000,000 in aggregate offering price.
- Security Type: Common Stock, $0.01 par value per share.
- Proceeds Usage: General corporate purposes, including future acquisitions, debt repayment, and working capital.
Debt levels, liquidity ratios, and operating margins are not disclosed in this document.
Material Changes
The material change reported is the establishment of the "2020 ATM Program" and the simultaneous termination of the prior 2019 equity distribution agreement. The new agreement involves a syndicate of nine sales agents, including BMO Capital Markets Corp., Barclays Capital Inc., and Wells Fargo Securities, LLC.
Guidance, Outlook, and Risks
Management Commentary: The Company intends to contribute net proceeds from the sale of shares to its Operating Partnership. Proceeds may be temporarily invested in interest-bearing short-term investments consistent with REIT qualification requirements.
Unusual Items: None reported in this filing.
Risks and Contingencies: The filing notes that sales will be made at prevailing market prices or negotiated prices. The offering will terminate upon the sale of the maximum aggregate amount or earlier termination of the agreement. The document includes a standard disclaimer that it does not constitute an offer to sell securities in any state where such an offer would be unlawful.
Investor Verification Checklist
- Verify the current market price of CTRE common stock to assess potential dilution impact if the full $500 million is sold.
- Review the full text of the Equity Distribution Agreement (Exhibit 1.1) for specific commission rates and termination clauses.
- Confirm the Company's current debt levels and liquidity position in the most recent 10-Q or 10-K to evaluate the necessity of the "debt repayment" use of proceeds.
- Monitor subsequent filings to track the actual volume of shares sold under the 2020 ATM Program.